BAILLIE GIFFORD & CO Q3 2019 Filing

Filed November 7, 2019

Portfolio Value

$87.9B

Holdings

225

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (225 positions)

#StockSharesValue% PortfolioType
201
CEVACEVA Inc
421,818$12.6M0.01%
202
VRSKVerisk Analytics
79,376$12.6M0.01%
203
AXGNAxogen Inc
989,400$12.3M0.01%
204
ABEVAmbev ADR
2,511$12.0M0.01%
205
LINDLindblad Expeditions Holdings
700,000$11.7M0.01%
206
Line Corp Sponsored Adr
318,120$11.4M0.01%
207
ResTORbio Inc
1,271,387$11.2M0.01%
208
ORTXUSDOrchard Therapeutics PLC ADR
925,000$11.0M0.01%
209
SHWSherwin-Williams Co
19,584$10.8M0.01%
210
BGTBlackRock Floating Rate Income
787,770$9.7M0.01%
211
AFWAlign Technology Inc
51,052$9.2M0.01%
212
VAREURVarian Medical Systems Inc
72,439$8.6M0.01%
213
WORKSlack Technologies Inc
341,276$8.1M0.01%
214
37MMRC Global
650,000$7.9M0.01%
215
Nucana Plc ADR
827,308$6.0M0.01%
216
XPHDXPioneer Floating Rate Trust
541,036$5.7M0.01%
217
Jianpu Technology Inc- ADR
2,085,056$5.2M0.01%
218
SINA Corp
131,550$5.2M0.01%
219
Blue Capital Reinsurance Holdings Fund (USD)
618,438$4.6M0.01%
220
Uxin ADR
1,776,100$4.4M0.00%
221
SLBSchlumberger
110,529$3.8M0.00%
222
KLDOKaleido Biosciences Inc
440,000$3.3M0.00%
223
SNAPSnap Inc
185,160$2.9M0.00%
224
NEANuveen Senior Income Fund
376,702$2.2M0.00%
225
SOHUSohu.com
200,140$2.0M0.00%
226
Blue Apron Holdings Inc
148,506$1.3M0.00%
PreviousPage 3 of 3